|
1) Chen RC, Chang SF, Su CL, et al. Prevalence, incidence, and mortality of PD. A door-to-door survey in Ilan County, Taiwan. Neurology. 2001; 57: 1679-86
|
|
|
|
2) Woo J, Lau E, Ziea E, et al. Prevalence of Parkinson's disease in a Chinese population. Acta Neurol Scand. 2004; 109: 228-31
|
|
|
|
|
3) Zhang L, Nie ZY, Liu Y, et al. The prevalence of PD in a nutritionally deficient rural population in China. Acta Neurol Scand. 2005; 112: 29-35
|
|
|
|
|
|
4) Zhang Z-X, Anderson DW, Huang J-B, et al. Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China. Mov Disord. 2003; 18; 764-72
|
|
|
|
|
|
5) Zhang Z-X, Roman GC, Hong Z, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet. 2005; 365: 595-7
|
|
|
|
|
|
6) Rocca WA. Prevalence of Parkinson's disease in China. Lancet Neurol. 2005; 4: 328-9
|
|
|
|
|
|
7) 田代邦雄. 本邦におけるParkinson病の疫学調査. 神経内科. 2002; 57: 467-70
|
|
|
|
|
8) 中島健二, 楠見公義, 山脇美香. 鳥取県米子市のパーキンソン病の疫学(第2報). 厚生労働科学研究費補助金(難治性疾患克服研究事業)神経変性疾患に関する調査研究班 平成18年度研究報告書. 2007. p. 124-6
|
|
|
|
|
|
9) Kusumi M, Yamawaki M, Wakutani Y, et al. Epidemiology of dementia with Lewy bodies and Parkinson's disease dementia in a Japanese rural town. Mov Disord. 2006; 21(Suppl 15): S534
|
|
|
|
|
|
10) Chan DKY, Dunne M, Wong A, et al. Pilot study of prevalence of Parkinson's disease in Australia. Neuroepidemiology. 2001; 20: 112-7
|
|
|
|
|
|
11) Chan DKY, Cordato D, Karr M, et al. Prevalence of Parkinson's disease in Sydney. Acta Neurol Scand. 2005; 111: 7-11
|
|
|
|
|
|
12) de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006; 5: 525-35
|
|
|
|
|
|
13) von Campenhausen S, Bornschein B, Wick R, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol. 2005; 15: 473-90
|
|
|
|
|
|
14) Tan LCS, Venketasubramanian N, Jamora RDG, et al. Incidence of Parkinson's disease in Singapore. Parkinsonism Related Disord. 2007; 13: 40-3
|
|
|
|
|
|
15) Tan LCS, Venketasubramanian N, Hong CY, et al. Prevalence of Parkinson disease in Singapore. Chinese vs Malays vs Indians. Neurology. 2004; 62: 1999-2004
|
|
|
|
|
|
16) Okubadejo NU, Bower J, Rocca WA, et al. Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies. Mov Disord. 2006; 21: 2150-6
|
|
|
|
|
|
17) Barbosa MT, Caramelli P, Maia DP, et al. Parkinsonism and Parkinson's disease in the elderly: A community-based survey in Brazil (the Bambui study). Mov Disord. 2006; 21: 800-8
|
|
|
|
|
|
18) Benito-Leon J, Bermejo-Pareja F, Rodriguez J, et al. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord. 2003; 18: 267-74
|
|
|
|
|
|
19) Taylor KSM, Counsell CE, Harris CE, et al. Screening for undiagnosed parkinsonism in people aged 65 years and over in the community. Parkinsonism Related Disord. 2006; 12: 79-85
|
|
|
|
|
|
20) de Lau LML, Schipper CMA, Hofman A, et al. Prognosis of Parkinson disease. Risk of dementia and mortality: The Rotterdam study. Arch Neurol. 2005; 62: 1265-9
|
|
|
|
|
|
21) Emre M. Dementia associated with Parkinson's disease. Lancet Neurol. 2003; 2: 229-37
|
|
|
|
|
|
22) Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord. 2005; 20: 1255-63
|
|
|
|
|
|
23) Aarsland D, Kvaloy JT, Andersen K, et al. The effect of age of onset of PD on risk of dementia. J Neurol. 2007; 254: 38-45
|
|
|
|
|
|
24) Kitayama M, Wada-Isoe K, Nakaso K, et al. Clinical evaluation of Parkinson's disease dementia: association with aging and visual hallucination. Acta Neurol Scand. 2007; 116: 190-5
|
|
|
|
|
|
25) Nomura T, Inoue Y, Miyake M, et al. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease. Mov Disord. 2006; 21: 380-4
|
|
|
|
|
|
26) Nomura T, Inoue Y, Nakashima K. Clinical characteristics of restless legs syndrome in patients with Parkinson's disease. J Neurol Sci. 2006; 250: 39-44
|
|
|
|
|
|
27) Nakashima K, Maeda M, Tabata M, et al. Prognosis of Parkinson's disease in Japan. Tottori University Parkinson's Disease Epidemiology (TUPDE) Study Group. Eur Neurol. 1997; 38 (Suppl 2): 60-3
|
|
|
|
|
|
28) D'Amelio M, Ragonese P, Morgante L, et al. Long-term survival of Parkinson's disease. A population-based study. J Neurol. 2006; 253: 33-7
|
|
|
|
|
|
29) Chen H, Zhang SM, Schwarzschild MA, et al. Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord. 2006; 21: 1002-7
|
|
|
|
|
|
30) Schupbach MWM, Welter ML, Bonnet AM, et al. Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus. Mov Disord. 2007; 22: 257-61
|
|
|
|
|
|
31) Nakaso K, Adachi Y, Yasui K, et al. Detection of compound heterozygous deletions in the parkin gene of fibroblasts in patients with autosomal recessive hereditary parkinsonism (PARK2). Neurosci Lett. 2006; 400: 44-7
|
|
|
|
|
|
32) Hardy J. No definitive evidence for a role for the environment in the etiology of Parkinson's disease. Mov Disrod. 2006; 21: 1790-1
|
|
|
|
|
|
33) Frigerio R, Elbaz A, Sanft KR, et al. Education and occupations preceding Parkinson disease: A population-based case-control study. Neurology. 2005; 65: 1575-83
|
|
|
|
|
|
34) Gorell JM, Peterson EL, Rybicki BA, et al. Multiple risk factors for Parkinson's disease. J Neurol Sci. 2004; 217: 169-74
|
|
|
|
|
|
35) Wastensson G, Hagberg S, Andersson E, et al. Parkinson's disease in diphenyl-exposed workers - A causal association？ Parkinosnism Related Disord. 2006; 12: 29-34
|
|
|
|
|
|
36) Dick S, Semple S, Dick F, et al. Occupational titles as risk factors for Parkinson's disease. Occup Med. 2007; 57: 50-6
|
|
|
|
|
|
37) Di Monte DA. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins？ Lancet Neurol. 2003; 2: 531-8
|
|
|
|
|
|
38) Ascherio A, Chen H, Weisskopf MG, et al. Pesticide exposure and risk for Parkinson's disease. Ann Neurol. 2006; 60: 197-203
|
|
|
|
|
|
39) Frigerio R, Sanft KR, Grossardt BR, et al. Chemical exposures and Parkinson's disease: A population-based case-control study. Mov Disord. 2006; 21: 1688-92
|
|
|
|
|
|
40) Dinis-Oliveira RJ, Remiao F, Carmo H, et al. Paraquat exposure as an etiological factor of Parkinson's disease. Neurotoxicology. 2006; 27: 1110-22
|
|
|
|
|
|
41) Brown TP, Rumsby PC, Capleton AC, et al. Pesticides and Parkinson's disease - Is there a link？ Environ Health Perspect. 2006; 114: 156-64
|
|
|
|
|
|
42) Powers KM, Smith-Weller T, Franklin GM, et al. Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology. 2003; 60: 1761-6
|
|
|
|
|
|
43) Park J, Yoo C-I, Sim CS, et al. A retrospective cohort study of Parkinson's disease in Korean shipbuilders. Neurotoxicology. 2006; 27: 445-9
|
|
|
|
|
|
44) Fored CM, Fryzek JP, Brandt L, et al. Parkinson's disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders. Occup Environ Med. 2006; 63: 135-40
|
|
|
|
|
|
45) Ritz B, Ascherio A, Checkoway H, et al. Pooled analysis of tobacco use and risk of Parkinson's disease. Arch Neurol. 2007; 64: 990-7
|
|
|
|
|
|
46) Mellick GD, Gartner CE, Silburn PA, et al. Passive smoking and Parkinson's disease. Neurology. 2006; 67: 179-80
|
|
|
|
|
|
47) Hu G, Antikainen R, Jousilahti P, et al. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care. 2007; 30: 842-7
|
|
|
|
|
|
48) Powers KM, Smith-Weller T, Franklin GM, et al. Diabetes, smoking, and other medical conditions in relation to Parkinson's disease. Parkinsonism Related Disord. 2006; 12: 185-9
|
|
|
|
|
|
49) de Lau LML, Koudstaal PJ, Hofman A, et al. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005; 58: 797-800
|
|
|
|
|
|
50) Hu G, Jousilahti P, Nissinen A, et al. Body mass index and the risk of Parkinson disease. Neurology. 2006; 67: 1955-9
|
|
|
|
|
|
51) Ma L, Zhang L, Gao XH, et al. Dietary factors and smoking as risk factors for PD in a rural population in China: a nested case-control study. Acta Neurol Scand. 2006; 113: 278-81
|
|
|
|
|
|
52) de Lau LML, Bornebroek M, Witteman JCM et al. Dietary fatty acids and the risk of Parkinson disease: The Rotterdam study. Neurology. 2005; 64: 2040-5
|
|
|
|
|
|
53) Chen H, O'Reilly E, McCullough ML, et al. Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiology. 2007; 165: 998-1006
|
|
|
|
|
|
54) de Lau LML, Koudsataal PJ, Witteman JCM, et al. Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology. 2006; 67: 315-8
|
|
|
|
|
|
55) Newmark HL, Newmark J. Vitamin D and Parkihnson's disease - a hypothesis. Mov Disord. 2007; 22: 461-8
|
|
|
|
|
|
56) Logroscino G, Sesso HD, Paffenbarger RS, Jr, et al. Physical activity and risk of Parkinson's disease: a prospective cohort study. J Neurol Neurosurg Psychiatry. 2006; 77: 1318-22
|
|
|
|
|
|
57) Goldman SM, Tanner CM, Oakes D, et al. Head injury and Parkinson's disease. Risk in twins. Ann Neurol. 2006; 60: 65-72
|
|
|
|
|